Clinical Trial Site

East Providence, Rhode Island 02914

0 studies enrolling now · 3 studies all time

What they study most

C3 Glomerulopathy (C3G), High Cardiovascular Risk, Hypertension, Iron Deficiency Anemia

Studies at this site

• Zilebesiran as Add-on Therapy in Patients With High Cardiovascular Risk and Hypertension Not Adequately Controlled by Standard of Care Antihypertensive Medications (KARDIA-3) — Completed
• Controlled Trial Evaluating Avacopan in C3 Glomerulopathy — Completed
• A Trial Comparing Ferumoxytol With Placebo for the Treatment of Iron Deficiency Anemia — Completed